UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Lassa antiviral LHF-535 protects guinea pigs from lethal challenge

Scientific reports, 2022-11, Vol.12 (1), p.19911-7, Article 19911

2022

Link zum Volltext

Verfügbarkeit prüfen

Coadministration of LHF-535 and favipiravir protects against experimental Junín virus infection and disease

Antiviral research, 2024-09, Vol.229, p.105952, Article 105952

2024

Link zum Volltext

Verfügbarkeit prüfen

1357 CD27 is a new promising T cell co-stimulatory target for the cancer immunotherapy – development and selection of a lead anti-CD27 agonist antibody

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1511-A1511

2023

Link zum Volltext

Verfügbarkeit prüfen

A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors

Frontiers in immunology, 2023-12, Vol.14, p.1311658-1311658

2023

Link zum Volltext

Verfügbarkeit prüfen

780 VISTA-101 – A phase 1/2 clinical trial of KVA12123, an engineered IgG1 targeting VISTA, alone and in combination with pembrolizumab in advanced solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A877-A877

2023

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors

Frontiers in immunology, 2024, Vol.15, p.1365240-1365240

2024

Link zum Volltext

Verfügbarkeit prüfen

A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation

PloS one, 2012-08, Vol.7 (8), p.e43332-e43332

2012

Link zum Volltext

Verfügbarkeit prüfen

Long-term Suppression of Experimental Arthritis Following Intramuscular Administration of a Pseudotyped AAV2/1-TNFR:Fc Vector

Molecular therapy, 2007-02, Vol.15 (2), p.264-269

2007

Link zum Volltext

Verfügbarkeit prüfen

Secretion of a TNFR:Fc Fusion Protein following Pulmonary Administration of Pseudotyped Adeno-Associated Virus Vectors

Journal of Virology, 2004-11, Vol.78 (22), p.12355-12365

2004

Link zum Volltext

Verfügbarkeit prüfen

Thalamocortical Connections in the Pond Turtle Pseudemys scripta elegans

Brain, behavior and evolution, 2005-01, Vol.65 (4), p.278-292

2005

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1637: A fully human anti-vista antibody as a promising therapy against poorly immunogenic tumors

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1637-1637

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract A60: CD27 an emerging immuno-oncology target at the cross-roads of innate and adaptive anti-tumor immune responses

Cancer immunology research, 2022-12, Vol.10 (12_Supplement), p.A60-A60

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4261: CD27 a new immuno-oncology target shaping innate and adaptive anti-tumor immune responses

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.4261-4261

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 972: VISTA expression in patients with advanced solid tumors: A potential biomarker in VISTA-101 clinical trial

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.972-972

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract PR005: Highly potent fully human anti-VISTA antibodies – A new target checkpoint inhibitor against immunosuppressive myeloid cells

Cancer immunology research, 2021-02, Vol.9 (2_Supplement), p.PR005-PR005

2021

Link zum Volltext

Verfügbarkeit prüfen

182 Highly potent fully human anti-VISTA antibodies – a new target checkpoint inhibitor against immunosuppressive myeloid cells

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A108-A108

2020

Link zum Volltext

Verfügbarkeit prüfen

578. Suppression of Inflammation Following Intramuscular Administration of Pseudotyped AAV-TNFR:Fc Vectors in a Rat Model of Arthritis

Molecular therapy, 2006-05, Vol.13 (S1), p.S223-S223

2006

Link zum Volltext

Verfügbarkeit prüfen

983. Repeat Intra-Articular Administration of AAV2 Vectors to Rat Joints

Molecular therapy, 2006-05, Vol.13 (S1), p.S378-S378

2006

Link zum Volltext

Verfügbarkeit prüfen

499. Improving the Stability of Ad-AAV Hybrid Vectors

Molecular therapy, 2006-05, Vol.13 (S1), p.S193-S193

2006

Link zum Volltext

Verfügbarkeit prüfen

880. Suppression of Inflammation in a Rat Model of Arthritis Following Intramuscular Administration of AAV-TNFR:Fc Vector Pseudotyped with AAV Type 1 Capsid

Molecular therapy, 2004-05, Vol.9 (S1), p.S335-S335

2004

Link zum Volltext

Verfügbarkeit prüfen

99. Long-term Expression of Soluble TNFR:Fc Protein Following Multiple Administrations of AAV-TNFR:Fc Vector Pseudotyped with Capsids of Alternate Serotypes

Molecular therapy, 2004-05, Vol.9 (S1), p.S39-S39

2004

Link zum Volltext

Verfügbarkeit prüfen

Hyperplasia and hypertrophy of chicken cardiac myocytes during posthatching development

American journal of physiology. Regulatory, integrative and comparative physiology, 1997-08, Vol.273 (2), p.518-R526

1997

Link zum Volltext

Verfügbarkeit prüfen

Hyperplasia and hypertrophy of chicken cardiac myocytes during posthatching development

American journal of physiology. Regulatory, integrative and comparative physiology, 1997-08, Vol.42 (2), p.R518-R526

1997

Link zum Volltext

Verfügbarkeit prüfen

Characterization of enzymatically isolated myocytes from the turtle, Chrysemys picta

Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 1996-12, Vol.115 (4), p.457-464

1996

Link zum Volltext

Verfügbarkeit prüfen

Combined Influences of Model Choice, Data Quality, and Data Quantity When Estimating Population Trends

PloS one, 2015-07, Vol.10 (7), p.e0132255-e0132255

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Animals
(12)
Humans
(8)
Life Sciences & Biomedicine
(8)
Gene Therapy
(7)
Proteins
(6)
Immunotherapy
(5)
Multidisciplinary Sciences
(5)
Science & Technology - Other Topics
(5)
Viruses
(5)
Antibodies
(4)
Arthritis
(4)
Cell Line
(4)
Female
(4)
Tumor Necrosis Factor-Tnf
(4)
Vectors
(4)
Antibodies, Neutralizing - Immunology
(3)
Arabidopsis
(3)
Biological And Medical Sciences
(3)
Disease
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Lassa antiviral LHF-535 protects guinea pigs from lethal challenge

Coadministration of LHF-535 and favipiravir protects against experimental Junín virus infection and disease

1357 CD27 is a new promising T cell co-stimulatory target for the cancer immunotherapy – development and selection of a lead anti-CD27 agonist antibody

A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors

780 VISTA-101 – A phase 1/2 clinical trial of KVA12123, an engineered IgG1 targeting VISTA, alone and in combination with pembrolizumab in advanced solid tumors

Corrigendum: A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors

A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation

Long-term Suppression of Experimental Arthritis Following Intramuscular Administration of a Pseudotyped AAV2/1-TNFR:Fc Vector

Secretion of a TNFR:Fc Fusion Protein following Pulmonary Administration of Pseudotyped Adeno-Associated Virus Vectors

Thalamocortical Connections in the Pond Turtle Pseudemys scripta elegans

Abstract 1637: A fully human anti-vista antibody as a promising therapy against poorly immunogenic tumors

Abstract A60: CD27 an emerging immuno-oncology target at the cross-roads of innate and adaptive anti-tumor immune responses

Abstract 4261: CD27 a new immuno-oncology target shaping innate and adaptive anti-tumor immune responses

Abstract 972: VISTA expression in patients with advanced solid tumors: A potential biomarker in VISTA-101 clinical trial

Abstract PR005: Highly potent fully human anti-VISTA antibodies – A new target checkpoint inhibitor against immunosuppressive myeloid cells

182 Highly potent fully human anti-VISTA antibodies – a new target checkpoint inhibitor against immunosuppressive myeloid cells

578. Suppression of Inflammation Following Intramuscular Administration of Pseudotyped AAV-TNFR:Fc Vectors in a Rat Model of Arthritis

983. Repeat Intra-Articular Administration of AAV2 Vectors to Rat Joints

499. Improving the Stability of Ad-AAV Hybrid Vectors

880. Suppression of Inflammation in a Rat Model of Arthritis Following Intramuscular Administration of AAV-TNFR:Fc Vector Pseudotyped with AAV Type 1 Capsid

99. Long-term Expression of Soluble TNFR:Fc Protein Following Multiple Administrations of AAV-TNFR:Fc Vector Pseudotyped with Capsids of Alternate Serotypes

Hyperplasia and hypertrophy of chicken cardiac myocytes during posthatching development

Hyperplasia and hypertrophy of chicken cardiac myocytes during posthatching development

Characterization of enzymatically isolated myocytes from the turtle, Chrysemys picta

Combined Influences of Model Choice, Data Quality, and Data Quantity When Estimating Population Trends

Suchergebnisse filtern